TELA Bio, Inc. (TELA) Gross margin 2017–2025
TELA Bio, Inc. (TELA) gross margin by fiscal year — reported gross profit divided by reported revenue.
67.7%FY2025 · since FY2017: 59.6% → 67.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 67.7% | +0.6 pp |
| FY2024 | 67.1% | -1.5 pp |
| FY2023 | 68.6% | +3.3 pp |
| FY2022 | 65.3% | +1.4 pp |
| FY2021 | 63.9% | +2.2 pp |
| FY2020 | 61.7% | +1.7 pp |
| FY2019 | 60.0% | +24.5 pp |
| FY2018 | 35.6% | -24.1 pp |
| FY2017 | 59.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Operating incomeTELA Operating marginTELA Operating cash flowTELA Free cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →